Stewart Gantt - Manhattan Associates Executive Americas
| MANH Stock | USD 280.40 8.51 3.13% |
Executive
Stewart Gantt is Executive Americas of Manhattan Associates
| Age | 50 |
| Address | 2300 Windy Ridge Parkway, Atlanta, GA, United States, 30339 |
| Phone | 770 955 7070 |
| Web | https://www.manh.com |
Manhattan Associates Management Efficiency
The company has return on total asset (ROA) of 0.2555 % which means that it generated a profit of $0.2555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.8978 %, meaning that it created $0.8978 on every $100 dollars invested by stockholders. Manhattan Associates' management efficiency ratios could be used to measure how well Manhattan Associates manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Manhattan Associates' Return On Capital Employed is increasing as compared to previous years. The Manhattan Associates' current Return On Equity is estimated to increase to 0.67, while Return On Tangible Assets are projected to decrease to 0.18. As of now, Manhattan Associates' Total Current Assets are increasing as compared to previous years. The Manhattan Associates' current Intangible Assets is estimated to increase to about 75.2 M, while Non Current Assets Total are projected to decrease to under 101.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Deep Varma | Alkami Technology | N/A | |
| Douglas Linebarger | Alkami Technology | 53 | |
| Jeff Young | Enfusion | N/A | |
| Bradley Herring | Enfusion | 53 | |
| Ignatius Njoku | Enfusion | N/A | |
| Alice JD | Paycor HCM | 52 | |
| Wayne McCulloch | Alkami Technology | N/A | |
| Douglas JD | Alkami Technology | 53 | |
| Alice Geene | Paycor HCM | 52 | |
| Matt Campobasso | Enfusion | N/A | |
| Neal Pawar | Enfusion | 52 | |
| Prerna Sachdeva | Alkami Technology | 46 | |
| Tiffany Sieve | Paycor HCM | N/A | |
| Gagan Kanjlia | Alkami Technology | N/A | |
| Carl Cross | Alkami Technology | N/A | |
| Rachel White | Paycor HCM | N/A | |
| Valeria Gutowski | Enfusion | 42 | |
| Brett Meager | Paycor HCM | N/A | |
| Swati Garodia | Paycor HCM | N/A | |
| Joe Frassica | Paycor HCM | N/A | |
| Kristy Ramundi | Alkami Technology | N/A | |
Management Performance
Manhattan Associates Leadership Team
Elected by the shareholders, the Manhattan Associates' board of directors comprises two types of representatives: Manhattan Associates inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Manhattan. The board's role is to monitor Manhattan Associates' management team and ensure that shareholders' interests are well served. Manhattan Associates' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Manhattan Associates' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Richards, Chief Legal Officer, Sr. VP and Secretary | ||
| Ann Ruckstuhl, Senior Officer | ||
| Eddie Capel, CEO and President and Director | ||
| Henri Seroux, Senior EMEA | ||
| Suzanne Hough, Senior Officer | ||
| Dennis Story, CFO, Executive VP and Treasurer | ||
| Linda Pinne, Senior Vice President Chief Accounting Officer, Controller | ||
| Raghav Sibal, Managing Zealand | ||
| Robert Howell, Sr. VP of Americas Sales | ||
| Rob Thomas, Executive Development | ||
| Bruce JD, Chief VP | ||
| Stewart Gantt, Executive Americas | ||
| Sanjeev Siotia, Executive CTO | ||
| Usha Tirumala, Executive India | ||
| Deepak Raghavan, Founder, Independent Director and Chairman of Nomination and Governance Committee | ||
| Dennis CPA, CFO VP |
Manhattan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Manhattan Associates a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.9 | ||||
| Return On Asset | 0.26 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 16.42 B | ||||
| Shares Outstanding | 61.08 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 98.80 % | ||||
| Number Of Shares Shorted | 2.39 M | ||||
| Price To Earning | 91.01 X |
Currently Active Assets on Macroaxis
When determining whether Manhattan Associates offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Manhattan Associates' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Manhattan Associates Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Manhattan Associates Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Manhattan Associates. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Manhattan Stock please use our How to Invest in Manhattan Associates guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manhattan Associates. If investors know Manhattan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manhattan Associates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.51 | Revenue Per Share 16.679 | Quarterly Revenue Growth 0.166 | Return On Assets 0.2555 | Return On Equity 0.8978 |
The market value of Manhattan Associates is measured differently than its book value, which is the value of Manhattan that is recorded on the company's balance sheet. Investors also form their own opinion of Manhattan Associates' value that differs from its market value or its book value, called intrinsic value, which is Manhattan Associates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manhattan Associates' market value can be influenced by many factors that don't directly affect Manhattan Associates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manhattan Associates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Manhattan Associates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manhattan Associates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.